We present two cases of Behcet\u27s Disease with severe eye problems along with oral and genital ulcerations. Both cases, initially were treated with steroids and oral immunosuppressive agents, but did not show a response and ocular disease became worse. Both the cases were kept on Infliximab therapy. an immediate positive response with improvement in vision and symptoms was seen. After initial infusions the ocular damage in both the cases stopped
BACKGROUND: To evaluate therapeutic outcomes of interferon alpha-2a (IFNalpha2a) treatment in patien...
Fabrizio Cantini1, Laura Niccoli1, Carlotta Nannini1, Olga Kaloudi1, Emanuele Cassarà1, M...
Background: The blocking of tumour necrosis factor-α (TNF-α) with the socalled anti TNF-α agents has...
Behcet disease (BD) is a multisystem vasculitic syndrome with clinical triad of oral aphthus ulcer,g...
Aim of the work: Ocular manifestations are the main cause of morbidity in Behcet's disease (BD). Inf...
Aim: To report a case of Behcet’s panuveitis and unilateral inflammatory maculopathy which was refra...
Behcet's disease (BD) is a chronic, relapsing inflammatory disease that involves multiple organs. Be...
Artículo de publicación SciELOThe efficacy and safety of repeated administration of infliximab was e...
BackgroundInfliximab, an anti-tumor necrosis factor-alpha antibody, has been reported to have excell...
Objectives. To evaluate the long-term efficacy and safety of infliximab in patients with Behçet’s d...
I report a case with ocular Behçet disease presenting as hypopyon-anterior uveitis refractory to con...
A 51-year-old man was diagnosed with Behcet's disease in 2001. The patient was resistant to all immu...
ecurrent oral and genital aphthous ulcerations are the hallmarks of Behçet’s disease. Up to now the...
Behcet's disease (BD) significantly increases morbidity and mortality, especially in young men. Whil...
Abstract The aim of the study was to assess the long-term efficacy and safety of Infliximab therapy...
BACKGROUND: To evaluate therapeutic outcomes of interferon alpha-2a (IFNalpha2a) treatment in patien...
Fabrizio Cantini1, Laura Niccoli1, Carlotta Nannini1, Olga Kaloudi1, Emanuele Cassarà1, M...
Background: The blocking of tumour necrosis factor-α (TNF-α) with the socalled anti TNF-α agents has...
Behcet disease (BD) is a multisystem vasculitic syndrome with clinical triad of oral aphthus ulcer,g...
Aim of the work: Ocular manifestations are the main cause of morbidity in Behcet's disease (BD). Inf...
Aim: To report a case of Behcet’s panuveitis and unilateral inflammatory maculopathy which was refra...
Behcet's disease (BD) is a chronic, relapsing inflammatory disease that involves multiple organs. Be...
Artículo de publicación SciELOThe efficacy and safety of repeated administration of infliximab was e...
BackgroundInfliximab, an anti-tumor necrosis factor-alpha antibody, has been reported to have excell...
Objectives. To evaluate the long-term efficacy and safety of infliximab in patients with Behçet’s d...
I report a case with ocular Behçet disease presenting as hypopyon-anterior uveitis refractory to con...
A 51-year-old man was diagnosed with Behcet's disease in 2001. The patient was resistant to all immu...
ecurrent oral and genital aphthous ulcerations are the hallmarks of Behçet’s disease. Up to now the...
Behcet's disease (BD) significantly increases morbidity and mortality, especially in young men. Whil...
Abstract The aim of the study was to assess the long-term efficacy and safety of Infliximab therapy...
BACKGROUND: To evaluate therapeutic outcomes of interferon alpha-2a (IFNalpha2a) treatment in patien...
Fabrizio Cantini1, Laura Niccoli1, Carlotta Nannini1, Olga Kaloudi1, Emanuele Cassarà1, M...
Background: The blocking of tumour necrosis factor-α (TNF-α) with the socalled anti TNF-α agents has...